دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Inside This Issue
doi : 10.1016/S1936-8798(22)02167-7
Volume 15, Issue 24, 26 December 2022, Pages A12-A16
Variation in Survival After Cardiopulmonary Arrest in Cardiac Catheterization Laboratories in the United States
Avnish Tripathi, MD, PHD, MPH,a Paul S. Chan, MD, MSC ,b Mazen S. Albagdadi, MD, MS C,c Mohammad Saud Khan, MD, a Varunsiri Atti, MD,d Arti Saraswat, MD, MPH,a Glenn A. Hirsch, MD, MHS, e Sammy Elmariah, MD, MPH,c Douglas E. Drachman, MD, c Deepak L. Bhatt, MD, MPH, f on behalf of the American Heart Association’s Get With the Guidelines Resuscitation Investigators
doi : 10.1016/j.jcin.2022.10.045
Volume 15, Issue 24, 26 December 2022, Pages 2463-2471
In-hospital cardiac arrest during cardiac catheterization is not uncommon. The extent of variation in survival after cardiac arrest occurring in the cardiac catheterization laboratory (CCL) and underlying factors are not well known.
In-Laboratory Cardiac Arrest: A Distinct Event Deserving Dedicated Study
Matthew I. Tomey, MD
doi : 10.1016/j.jcin.2022.10.053
Volume 15, Issue 24, 26 December 2022, Pages 2472-2474
Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention
Christopher P. Kovach, MD, MSC ,a,b Annika Hebbe, MS, b,c Thomas J. Glorioso, MS, b,c Christopher Barrett, MD,a Anna E. Barón, PHD, d Kreton Mavromatis, MD, e Javier A. Valle, MD, MSCS, a,f Stephen W. Waldo, MD
doi : 10.1016/j.jcin.2022.11.002
Volume 15, Issue 24, 26 December 2022, Pages 2475-2486
Anatomical scoring systems have been used to assess completeness of revascularization but are challenging to apply to large real-world datasets.
Can Automating the SYNTAX Score Move Practice Beyond the Angiogram Alone?
Morton J. Kern, MD, Arnold H. Seto, MD, MPA
doi : 10.1016/j.jcin.2022.10.056
Volume 15, Issue 24, 26 December 2022, Pages 2487-2489
Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China Trial
Rui Zhang, MD,a,b, * Hao-Yu Wang, MD,a,b, * Kefei Dou, MD, a,b Dong Yin, MD, b Chenggang Zhu, MD,b Lei Feng, MD, b Yujie Zhou, MD, c Jun Pu, MD,d Qi Zhang, MD, e Hongwei Pan, MD, f Jie Mi, MD, g Fei Ye, MD, h Xiang Cheng, MD, i Ning Guo, MD, j Changdong Guan, MS C,k Lei Song, MD, k Shubin Qiao, MD, k Shengxian Tu, PHD, l Bo Xu, MBBS,k,m Gregg W. Stone, MD, n on behalf of the FAVOR III China Study Group
doi : 10.1016/j.jcin.2022.10.014
Volume 15, Issue 24, 26 December 2022, Pages 2490-2502
Functional complete revascularization (FCR) after percutaneous coronary intervention (PCI) as determined by the residual functional SYNTAX score (rFSS) based on pressure wire fractional flow reserve assessment has been associated with an improved prognosis.
QFR Facilitated Functional Lesion Assessment to Guide Revascularization: The Next Paradigm Shift?∗
Timothy D. Henry, MD, Dean J. Kereiakes, MD
doi : 10.1016/j.jcin.2022.10.061
Volume 15, Issue 24, 26 December 2022, Pages 2503-2505
Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease
Carlos Collet, MD, PHD, a, * Damien Collison, MBBCH ,b,c, * Takuya Mizukami, MD, PHD, a,d, * Peter McCartney, MBCHB, b,c Jeroen Sonck, MD, P HD, a Thomas Ford, MD, PHD, b,c Daniel Munhoz, MD, PH D, a Colin Berry, MD, P HD, b,c Bernard De Bruyne, MD, PH D, a,e Keith Oldroyd, MBC HBb
doi : 10.1016/j.jcin.2022.09.048
Volume 15, Issue 24, 26 December 2022, Pages 2506-2518
An increase in fractional flow reserve (FFR) after percutaneous coronary intervention (PCI) is associated with improvement in angina. Coronary artery disease (CAD) patterns (focal vs diffuse) influence the FFR change after stenting and may predict angina relief.
In the Beginning There Was Angina Pectoris, at the End There Was Still Angina Pectoris
Patrick W. Serruys, MD, PHD, a,b,c Shigetaka Kageyama, MD,a,b Scot Garg, MD, P HD, d Yoshinobu Onuma, MD, PH D
doi : 10.1016/j.jcin.2022.10.036
Volume 15, Issue 24, 26 December 2022, Pages 2519-2522
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients
D. Scott Lim, MD, a Robert L. Smith, MD,b Linda D. Gillam, MD, MPH, c Firas Zahr, MD,d Scott Chadderdon, MD, d Raj Makkar, MD,e Ralph Stephan von Bardeleben, MD, P HD, f Robert M. Kipperman, MD,c Andrew N. Rassi, MD,g Molly Szerlip, MD,b Scott Goldman, MD, h Ignacio Inglessis-Azuaje, MD, i Pradeep Yadav, MD,j Philipp Lurz, MD, P HD, k Charles J. Davidson, MD,l Mubashir Mumtaz, MD, m Hemal Gada, MD,m Saibal Kar, MD, n Susheel K. Kodali, MD,o Roger Laham, MD,p William Hiesinger, MD,q Neil P. Fam, MD, r Mirjam Keßler, MD,s William W. O’Neill, MD, t Brian Whisenant, MD,u Chad Kliger, MD,v Samir Kapadia, MD, w Volker Rudolph, MD, x Joseph Choo, MD,y James Hermiller, MD, z Michael A. Morse, MD,aa Niklas Schofer, MD,bb Sameer Gafoor, MD,cc Azeem Latib, MD, dd Konstantinos Koulogiannis, MD,c Leo Marcoff, MD, c Jörg Hausleiter, MD, ee on behalf of CLASP IID Pivotal Trial Investigators
doi : 10.1016/j.jcin.2022.09.005
Volume 15, Issue 24, 26 December 2022, Pages 2523-2536
Severe symptomatic degenerative mitral regurgitation (DMR) has a poor prognosis in the absence of treatment, and new transcatheter options are emerging.
Mitral Transcatheter Edge-to-Edge Repair: A Choice!
John G. Webb, MD, Robert H. Boone, MD
doi : 10.1016/j.jcin.2022.10.005
Volume 15, Issue 24, 26 December 2022, Pages 2537-2540
Early Outcomes of 2 Mitral Valve Transcatheter Leaflet Approximation Devices: A Propensity Score–Matched Multicenter Comparison
Victor Mauri, MD, a Atsushi Sugiura, MD, PHD, b Max Spieker, MD, c Christos Iliadis, MD, a Patrick Horn, MD, c Can Öztürk, MD,b Christian Besler, MD, d Matthias Riebisch, MD, e Osamah Al-Hammadi, MD, f Tobias Ruf, MD, g Muhammed Gerçek, MD, h Christina Grothusen, MD,i,j Michael Mehr, MD,k Marc Ulrich Becher, MD,b Christoph Mues, MD, i Niklas Boeder, MD, f Felix Kreidel, MD, g Kai Friedrichs, MD, h Ralf Westenfeld, MD, c Daniel Braun, MD,k Stephan Baldus, MD,a Tienush Rassaf, MD, e Holger Thiele, MD, d Georg Nickenig, MD, b Jörg Hausleiter, MD, k Helge Möllmann, MD, i Malte Kelm, MD,c Volker Rudolph, MD,h Ralph Stephan von Bardeleben, MD, g Holger M. Nef, MD, f Peter Luedike, MD,e Philipp Lurz, MD,d Roman Pfister, MD
doi : 10.1016/j.jcin.2022.10.008
Volume 15, Issue 24, 26 December 2022, Pages 2541-2551
In addition to the edge-to-edge MitraClip repair system, the edge-to-spacer PASCAL repair system was approved for percutaneous treatment of severe mitral regurgitation (MR). Comparative data are lacking.
A Tale of 2 TEERs: The Toolbox Expand
Neil P. Fam, MD, MS
doi : 10.1016/j.jcin.2022.10.047
Volume 15, Issue 24, 26 December 2022, Pages 2552-2553
Mitral Valve Transcatheter Edge-to-Edge Repair Using MitraClip or PASCAL: A Multicenter Propensity Score–Matched Comparison
Leonhard Schneider, MD,a Sinisa Markovic, MD,a Katharina Mueller,a Dominik Felbel, MD, a Muhammed Gerçek, MD,b Kai Friedrichs, MD,b Lukas Stolz, MD, c Volker Rudolph, MD, b Jörg Hausleiter, MD,c Wolfgang Rottbauer, MD,a Mirjam Keßler, MD
doi : 10.1016/j.jcin.2022.10.028
Volume 15, Issue 24, 26 December 2022, Pages 2554-2567
Since its introduction in 2003, Abbott’s MitraClip (MC) has become the most established catheter-based treatment for mitral regurgitation (MR). Recent approval of Edwards Lifescience’s PASCAL device has extended the field of TEER.
The Expanding Landscape of Transcatheter Mitral Valve Therapies: Perplexity or an Opportunity for Precision Medicine
Ahmed El Shaer, MD, a Mohamad Alkhouli, MD
doi : 10.1016/j.jcin.2022.10.057
Volume 15, Issue 24, 26 December 2022, Pages 2568-2570
Late Fabric and Peridevice Leak of Watchman Left Atrial Appendage Occluder During Long-Term Follow-Up
Tarun Chakravarty, MD, John Friedman, MD, Florian Rader, MD, Raj R. Makkar, MD
doi : 10.1016/j.jcin.2022.09.043
Volume 15, Issue 24, 26 December 2022, Pages 2571-2572
Subclavian Artery Access for Transcatheter Aortic Valve Replacement in a Right Aortic Arch
Yu Hohri, MD, PH D, a Kan Zen, MD, P HD, b Hidetake Kawajiri, MD, PHD, a Satoaki Matoba, MD, PH D, b Hitoshi Yaku, MD, P HD
doi : 10.1016/j.jcin.2022.08.028
Volume 15, Issue 24, 26 December 2022, Pages 2573-2574
vICE-Guided T-TEER in a Patient Without TEE Windows
Gagan D. Singh, MD, Edris Aman, MD, Tai Pham, MD, Jason H. Rogers, MD, Kwame Atsina, MD, Thomas W.R. Smith, MD
doi : 10.1016/j.jcin.2022.08.056
Volume 15, Issue 24, 26 December 2022, Pages e245-e247
A Novel Approach for Coronary Steal Syndrome Due to Left Internal Mammary Artery Side Branch
Aziz Inan Celik, MD, Tahir Bezgin, MD, Metin Cagdas, PHD
doi : 10.1016/j.jcin.2022.09.037
Volume 15, Issue 24, 26 December 2022, Pages e249-e250
Oral Anticoagulant Dose Adjustment After TAVR: The Role of Closure Time With Adenosine Diphosphate
Kensuke Matsushita, MD, PhD Antonin Trimaille, MD Benjamin Marchandot, MD Patrick Ohlmann, MD, PhD *Olivier Morel, MD, PhD
doi : 10.1016/j.jcin.2022.10.018
Volume 15, Issue 24, 26 December 2022, Page 2575
Reply: Oral Anticoagulant Dose Adjustment After TAVR: The Role of Closure Time With Adenosine Diphosphate
Jean-Philippe Collet, MD, PhD Eric Van Belle, MD, PhD Paul Guedeney, MD, PhD Eric Vicaut, MD, PhD Gilles Montalescot, MD, PhD
doi : 10.1016/j.jcin.2022.10.046
Volume 15, Issue 24, 26 December 2022, Page 2576
Preprocedural Intravenous Diuresis to Facilitate Tricuspid Valve Intervention
Anas Merdad, MBBS Neil P. Fam, MD, MSc Kim A. Connelly, MBBS, PhD Daniel Hagemeyer, MD Sikander Texiwala, MD *Géraldine Ong, MD, MSc
doi : 10.1016/j.jcin.2022.08.030
Volume 15, Issue 24, 26 December 2022, Pages 2576-2578
Echocardiographic Pulmonary Artery Systolic Pressure Is Not Reliable for RV-PA Coupling in Transcatheter Tricuspid Valve Annuloplasty
Muhammed Gerçek, MD Maria I. Körber, MD Akhil Narang, MD Kai P. Friedrichs, MD Jyothy J. Puthumana, MD Tanja K. Rudolph, MD James D. Thomas, MD Roman Pfister, MD Charles J. Davidson, MD Volker Rudolph, MD
doi : 10.1016/j.jcin.2022.09.026
Volume 15, Issue 24, 26 December 2022, Pages 2578-2580
